We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Bird's-eye view

18 April 2017 By Robert Cyran

The U.S. pill distributor said for the third time since October that falling prices would hurt profit. Cardinal Health underscored the hard times ahead by paying $6 bln for Medtronic’s medical-supplies unit to diversify. Other links in the pharmaceuticals chain will suffer, too.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)